Nanomembranas multifuncionales como biosensores inteligentes conformables para una monitorización clínica no invasiva (BIOSINTEL)

José Manuel García Torres

Universitat politècnica de Catalunya. Barcelona

The objective is to develop a new family of nanostructured flexible electronic materials to improve the adhesion and integration capacity of electronic devices on biological tissues (skin), thus favoring precise, reliable, non-invasive, continuous in-situ monitoring over time and of low cost.

Development of an in-situ gelation hydrogel for the controlled release of drugs with antidepressant potential by subcutaneous administration.

Fernando Yáñez Gómez

Universidad de las Islas Baleares. Palma de Mallorca

Development of a hydrogel capable of controlled release of potential antidepressant molecules, which after in vitro characterization, can be administered subcutaneously in adolescent-age animals.

Unravelling the coeliac immunome during disease Outcome

Dr. David Bernardo Ordiz

Instituto de Biomedicina y Genética Molecular. Valladolid

Our hypothesis is that by performing an in depth unbiased mucosal and circulating immunome characterization of CD patients (both GFD-treated but also at diagnose) we will unravel the immune fingerprint of the disease.

Chronocrit study: evaluation of sleep and circadian health of critical patients

Dr. Adriano Targa Días Santos

Institut de Recerca Biomèdica. Lleida

The objective of the research is to improve the management of sleep health and circadian rhythms after a critical illness, evaluating the role of miRNA expression profiles in the identification of sleep disturbances and circadian rhythms in critically ill patients during their stay in the ICU. , short (3 months after hospital discharge) and long term (12 months after hospital discharge).

Artificial intelligence (IA) to facilitate surgery. Use Case Proof-of-concept in Breast Cancer Surgery for a New Innovative Artificial Intelligence Automated Pre-Anesthesia Risk Assessment Tool

Dr. Andrés Ancor Serrano Afonso

Hospital Universitari de Bellvitge. IDIBELL. Hospitalet de Llobregat

The objective is to develop an artificial intelligence (AI) tool for pre-anesthesia risk assessment, carrying out a proof of concept of use case in breast cancer surgery, and proceeding to its automation through Machine Learning.

Plantes Mediterrànies contra els super bacteris del tracte respiratori

Dra. Sara Quero Blanca

Institut d’Investigació i Innovació Parc Taulí (I3PT). Sabadell

The objective is to evaluate the toxicity of 5 essential oils from Mediterranean plants against two lung cell lines. On the one hand, that of the minimum concentration of each oil with a cytotoxic effect in the 2 cell lines and, on the other hand, that of the minimum concentration of each oil with induction of apoptosis in the two cell lines.

Dr. Manel Esteller

Josep Carreras Leukaemia Research Institute

The scientific committee of the Jané Mateu Foundation has awarded the prize to Dr. Manel Esteller. Graduated in medicine from the University of Barcelona, ​​he has developed invaluable work in the field of Epigenetics, currently being recognized as one of the most expert people internationally. Author of more than 200 scientific articles and editor of various publications, he currently holds the position of president of the Epigenetics Society.

His research has contributed and facilitated the complementation of scientific paradigms, demonstrating that external factors have a relevant influence, directly modifying genes and their expression.